According to the results of a cohort study in JAMA internal medicine. Read more
Healio editors have compiled the most read respiratory news published in May.
Highlights include the FDA issuing marketing denial orders to Juul Labs for all of their vaping devices and related products in the United States; the US news and world report‘s Best Children’s Hospitals for Respirology and Pulmonary Surgery; a study that identified eight asthma-COPD overlap signals; brensocatib did not improve the clinical status of COVID-19; and more.
Read these articles, and more, below, in no particular order.
FDA Denies Approval to Market Juul Vaping Products
In late June, the FDA issued marketing denial orders to Juul Labs for all of their vaping devices and related products. As a result, the company should stop selling and distributing these products, and those currently on the US market should be discontinued. SheaveD After
Texas Children’s Hospital Ranked #1 in the United States for Respirology and Pulmonary Surgery
Texas Children’s Hospital ranked #1 on US News and World Reports list of best children’s hospitals for pulmonology and lung surgery. Read more
Racial and ethnic bias in pulse oximetry accuracy may have delayed COVID-19 treatment for some
Continued use of CPAP may reduce mortality risk in people with obstructive sleep apnea
According to research published in Chest. Read more
Overuse of asthma reliever inhalers common, varies by practice
According to new data published in the British Journal of General Medicine. Read more
New lung cancer guidelines have reduced some screening disparities
New lung cancer screening guidelines from the U.S. Preventive Services Task Force, which lowered the age of inclusion and smoking intensity to qualify as high risk, led to an increase in the proportion of black people screened. Read more
California’s historic redlining linked to worst COVID-19 outcomes
SAN FRANCISCO — Residents affected by historic redlining in California communities had worse COVID-19 outcomes, according to new data presented at the American Thoracic Society’s international conference. Read more
Brensocatib did not improve the clinical status of patients with severe COVID-19
SAN FRANCISCO — Brensocatib, an investigational oral dipeptidyl peptidase 1 inhibitor, did not improve the clinical status of patients hospitalized with severe COVID-19 at 29 days, according to results from the STOP-COVID19 trial. Read more
Study sheds light on race/ethnicity differences in perception of healthcare delivery
SAN FRANCISCO — A new study highlights disparities in perceptions of health care satisfaction among black and Hispanic patients compared to white patients, according to data presented at the American Thoracic Society’s international conference. Read more
Study identifies eight asthma-COPD overlap signals
A new study has identified eight asthma-COPD overlapping signals that the researchers believe appear to represent loci that predispose patients to type 2 inflammation and therefore to serious long-term consequences of asthma, the researchers reported. in Chest. Read more